Get startedLog in
    Picture of Redcare Pharmacy NV logo

    RDC — Redcare Pharmacy NV Income Statement

    0.000.00%
    de flag iconLast trade - 00:00
    Consumer DefensivesSpeculativeMid CapValue Trap
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Redcare Pharmacy NV, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

    2021
    December 31st
    2022
    December 31st
    2023
    December 31st
    2024
    December 31st
    2025
    December 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IFRS
    IFRS
    IFRS
    IFRS
    IFRS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue1,0601,2041,7992,3712,941
    Cost of Revenue
    Gross Profit267332440546664
    Selling / General / Administrative Expenses
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses1,1261,2741,8162,4102,963
    Operating Profit-65.7-69.2-17.3-39-21.7
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes-77.9-84.1-14.3-47.8-47.7
    Provision for Income Taxes
    Net Income After Taxes-74.2-77.6-11.6-46.4-39.4
    Minority Interest
    Net Income Before Extraordinary Items
    Net Income-74.2-77.6-12-45.5-37.7
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income-74.2-77.6-12-45.5-37.7
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS-3.01-3.75-0.299-2.25-1.67
    Dividends per Share